
浏览全部资源
扫码关注微信
河北医科大学第二医院东院普外科,河北 唐山 050000
高飞,E-mail:aih1s4@sina.com
纸质出版日期:2024-11-25,
收稿日期:2023-07-18,
移动端阅览
高飞,乔秋阁.经鼻肠梗阻导管置入术治疗妊娠期肠梗阻的效果分析[J].局解手术学杂志,2024,33(11):967-969.
GAO Fei,QIAO Qiu-ge.Analysis of the effect of nasal intestinal obstruction catheter placement in the treatment of intestinal obstruction during pregnancy[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(11):967-969.
高飞,乔秋阁.经鼻肠梗阻导管置入术治疗妊娠期肠梗阻的效果分析[J].局解手术学杂志,2024,33(11):967-969. DOI: 10.11659/jjssx.07E023074.
GAO Fei,QIAO Qiu-ge.Analysis of the effect of nasal intestinal obstruction catheter placement in the treatment of intestinal obstruction during pregnancy[J].JOURNAL OF REGIONAL ANATOMY AND OPERATIVE SURGERY,2024,33(11):967-969. DOI: 10.11659/jjssx.07E023074.
目的
2
探讨经鼻肠梗阻导管置入术治疗妊娠期肠梗阻的效果。
方法
2
通过随机数字表法将2021年1月至2022年1月本院接收的92例妊娠期肠梗阻患者分为观察组(46例,采用经鼻肠梗阻导管置入术治疗)和对照组(46例,采用普通鼻胃管进行胃肠减压)。观察2组患者疗效、胃肠功能以及免疫功能情况,并记录母婴结局。
结果
2
观察组患者总有效率高于对照组(
P
<
0.05)。2组患者治疗后的CD
4
+
T淋巴细胞水平上升,IgG、IgA、IgM、CD
8
+
T淋巴细胞水平降低,且观察组均优于对照组,差异有统计学意义(
P
<
0.05)。观察组患者治疗后肠鸣音恢复时间、肛门排气时间、首次排便时间均早于对照组(
P
<
0.05)。观察组中有42例(91.30%)患者经保守治疗后足月分娩,母婴结局良好,对照组中有35例(76.09%)经保守治疗后康复出院,2组患者康复出院率比较差异具有统计学意义(
P
<
0.05)。
结论
2
经鼻肠梗阻导管置入术能有效改善妊娠期肠梗阻患者胃肠功能,提高免疫功能及康复率。
Objective
2
To explore the effect of nasal intestinal obstruction catheter placement in the treatment of intestinal obstruction during pregnancy.
Methods
2
A total of 92 patients with intestinal obstruction during pregnancy admitted to our hospital from January 2021 to January 2022 were divided into the observation group (46 cases,treated with nasal intestinal obstruction catheter placement) and the control group (46 cases,treated with ordinary nasogastric tube for gastrointestinal decompression) by random number table method.The curative effect,gastrointestinal function and immune function of patients in the two groups were observed,and the maternal and infant outcomes were recorded.
Results
2
The total effective rate of patients in the observation group was higher than that in the control group(
P
<
0.05). After treatment,the levels of CD
4
+
T lymphocytes increased in both groups of patients,while the levels of IgG,IgA,IgM,and CD
8
+
T lymphocytes decreased,and those in the observation group were superior to the control group,with statistically significant differences (
P
<
0.05). The recovery time of bowel sounds,anal exhaust time and first defecation time after treatment in the observation group were earlier than those in the control group (
P
<
0.05). A total of 42 patients (91.30%) in t
he observation group delivered at full term after conservative treatment,with good maternal and infant outcomes; 35 patients (76.09%) in the control group recovered and discharged after conservative treatment,there was a statistically significant difference in the recovery and discharge rate between patients of the two groups(
P
<
0.05).
Conclusion
2
Nasal intestinal obstruction catheter placement can effectively improve gastrointestinal function of patients with intestinal obstruction during pregnancy,and enhance the immune function and recovery rate.
经鼻肠梗阻导管妊娠期肠梗阻肠鸣音恢复免疫功能母婴结局
nasal intestinal obstruction catheterintestinal obstruction during pregnancyrecovery of bowel soundsimmune functionmaternal and infant outcomes
Kim K,Ko M,Sim HC,et al.Intussusception caused by colon cancer in pregnancy[J].Korean J Gastroenterol,2019,73(6):355-359.doi:10.4166/kjg.2019.73.6.355http://dx.doi.org/10.4166/kjg.2019.73.6.355.
Mukherjee R,Samanta S.Surgical emergencies in pregnancy in the era of modern diagnostics and treatment[J].Taiwan J Obstet Gynecol,2019,58(2):177-182.doi:10.1016/j.tjog.2019.01.001http://dx.doi.org/10.1016/j.tjog.2019.01.001.
高飞,李景,张少君,等.经鼻型肠梗阻导管治疗妊娠期肠梗阻疗效观察[J].现代中西医结合杂志,2020,29(25):2800-2803.doi:10.3969/j.issn.1008-8849.2020.25.015http://dx.doi.org/10.3969/j.issn.1008-8849.2020.25.015.
陆佳明,韦维,梁亮,等.经鼻型肠梗阻导管联合早期肠内营养治疗黏连性肠梗阻的临床疗效观察[J].广西医科大学学报,2019,36(2):298-301.doi:10.16190/j.cnki.45-1211/r.2019.02.034http://dx.doi.org/10.16190/j.cnki.45-1211/r.2019.02.034.
胡刚,谢长远,王立孟.经鼻型肠梗阻导管治疗急性肠梗阻患者疗效及其血清晚期糖基化终末产物人肠脂肪酸结合蛋白水平变化[J].中国药物与临床,2019,19(13):2237-2240.doi:10.11655/zgywylc2019.13.045http://dx.doi.org/10.11655/zgywylc2019.13.045.
郑芝田.胃肠病学[M].第2版.北京:人民卫生出版社,1993:148-155.
曹泽毅.中华妇产科学[M].第2版.北京:人民卫生出版社,2008:585-586.
李政,郑晓强,王罡.不同类型肠梗阻应用经鼻型肠梗阻导管治疗的效果比较[J].基层医学论坛,2020,24(19):2669-2670.doi:10.19435/j.1672-1721.2020.19.003http://dx.doi.org/10.19435/j.1672-1721.2020.19.003.
张琚芳,李祥雯,朱启英.对妊娠期肠梗阻误诊的探讨和13例临床分析[J].新疆医科大学学报,2020,43(7):923-925.doi:10.3969/j.issn.1009-5551.2020.07.018http://dx.doi.org/10.3969/j.issn.1009-5551.2020.07.018.
赵海龙,李宁,马俊英.经鼻型肠梗阻导管治疗妊娠期肠梗阻的临床意义研究[J].中外医疗,2020,39(36):41-43.doi:10.16662/j.cnki.1674-0742.2020.36.041http://dx.doi.org/10.16662/j.cnki.1674-0742.2020.36.041.
张超,李昂,曹锋,等.经鼻肠梗阻导管治疗老年机械性小肠梗阻的疗效分析[J].中华普通外科杂志,2021,36(5):327-331.doi:10.3760/cma.j.cn113855-20201122-00878http://dx.doi.org/10.3760/cma.j.cn113855-20201122-00878.
黄湘俊,王永恒.DSA引导下经鼻肠梗阻导管置入治疗难治性粘连性肠梗阻[J].中国介入影像与治疗学,2020,17(2):80-83.doi:10.13929/j.issn.1672-8475.2020.02.004http://dx.doi.org/10.13929/j.issn.1672-8475.2020.02.004.
杨杰,马宏飞,肖开提·依不拉音,等.经鼻肠梗阻导管置入术治疗急性肠梗阻伴晚期胃癌患者中远期疗效及对炎性因子影响[J].临床军医杂志,2020,48(4):422-423.doi:10.16680/j.1671-3826.2020.04.22http://dx.doi.org/10.16680/j.1671-3826.2020.04.22.
姜健,薛谦,李建超.内镜下经鼻型肠梗阻导管对肠梗阻患者胃肠功能及免疫应激的影响[J].北京医学,2020,42(8):772-774.doi:10.15932/j.0253-9713.2020.08.019http://dx.doi.org/10.15932/j.0253-9713.2020.08.019.
钱晶瑶,石磊,施丹,等.新型鼻胃镜辅助法留置经鼻型肠梗阻导管的应用价值[J].天津医药,2019,47(1):1179-1182.doi:10.11958/20191595http://dx.doi.org/10.11958/20191595.
张宏昭,石鹏,王翠敏.益气活血法对术后早期炎性肠梗阻患者炎症因子水平、免疫功能及肠道菌群的影响[J].广西医学, 2023,45(12):1439-1443.doi:10.11675/j.issn.0253-4304.2023.12.10http://dx.doi.org/10.11675/j.issn.0253-4304.2023.12.10.
Akbas A,Koyuncu S,Hacım NA,et al.Can HALP (hemoglobin, albumin,lymphocytes,and platelets) score differentiate between malignant and benign causes of acute mechanic intestinal obstruction[J].Cancer Biother Radiopharm,2022,37(3):199-204.doi:10.1089/cbr.2021.0277http://dx.doi.org/10.1089/cbr.2021.0277.
Du L,Zhang Y,Ji S,et al.Mechanisms of Zhenwu decoction for the treatment of renal fibrosis at various stages:what is the role of corynebacterium?[J].Front Microbiol,2022,13:913465.doi:10.3389/fmicb.2022.913465http://dx.doi.org/10.3389/fmicb.2022.913465.
Ben Khelil M,Godet Y,Abdeljaoued S,et al.Harnessing antitumor CD4+ T cells for cancer immunotherapy[J].Cancers (Basel),2022,14(1):260.doi:10.3390/cancers14010260http://dx.doi.org/10.3390/cancers14010260.
0
浏览量
1
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621